Global Cervical Cancer Diagnostics Market to Grow at 4.56% During 2025-2033, Impelled by Awareness Campaigns

January 03, 2025 | Healthcare

According to the latest report by IMARC Group, titled “Cervical Cancer Diagnostics Market Report by Test Type (Pap Testing, HPV Testing, Cervical Biopsies, Colposcopy, and Others), Age Group (20 to 35 Years, Above 35 Years), and Region 2025-2033,” the global cervical cancer diagnostics market reached a value of USD 8.3 Billion in 2024. Cervical cancer refers to a type of cancer that occurs in the cervix, the lower part of the uterus. There are two main types of cervical cancer, namely adenocarcinoma and squamous cell carcinoma. Cervical cancer diagnosis is performed through various advanced laboratory tests, tools and procedures to evaluate abnormal cells and strains of human papillomavirus (HPV). These tests and procedures include conization, punch biopsy, endocervical curettage and the electrical wire loop for a thorough examination of the cervix during colposcopy. These procedures are followed by blood tests, body computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET) scans to determine the progress of the disease.

Global Cervical Cancer Diagnostics Market Trends:

The rising prevalence of sexually transmitted infections (STIs) is one of the key factors driving the global cervical cancer diagnostics market growth. Other than this, the growing adoption of advanced diagnostic procedures for the early detection of cervical cancer, along with various awareness campaigns organized by government and non-government entities, is also contributing to the market growth. In line with this, there is a growing consciousness regarding the availability of effective treatment and diagnosis methods, which is further contributing to the market growth. Leading players are developing home-based HPV testing kits to offer convenience to consumers, which is acting as another major growth-inducing factor. Additionally, the escalating demand for minimally invasive screening procedures is supporting the market growth. Moreover, the growing emphasis on developing low-cost and efficient testing products is creating a positive outlook for the market. Looking forward, the market value is projected to reach USD 12.7 Billion by 2033, expanding at a CAGR of 4.56% during 2025-2033.

Market Summary:

  • On the basis of the test type, the market has been classified into pap testing, HPV testing, cervical biopsies, colposcopy and others.
  • Based on the age group, the market has been bifurcated into 20 to 35 years and above 35 years.
  • On a regional basis, the market has been spread across North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others) and Middle East and Africa.
  • The competitive landscape of the market has also been examined, with some of the key players being Abbott Laboratories, Arbor Vita Corporation, Becton, Dickinson and Company, Cooper Surgical Inc., F. Hoffmann-La Roche AG, Guided Therapeutics Inc., Hologic Inc., Qiagen, Quest Diagnostics Incorporated and Siemens Healthcare GmbH.
     

Report Scope:

Report Features Details
Base Year of the Analysis 2024
Historical Period 2019-2024
Forecast Period 2025-2033
Units Billion USD
Segment Coverage Test Type, Age Group, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Abbott Laboratories, Arbor Vita Corporation, Becton, Dickinson and Company, Cooper Surgical Inc., F. Hoffmann-La Roche AG, Guided Therapeutics Inc., Hologic Inc., Qiagen, Quest Diagnostics Incorporated and Siemens Healthcare GmbH
Customization Scope 10% Free Customization
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group

USA: +1-631-791-1145
Email: sales@imarcgroup.com
Website: https://www.imarcgroup.com
Follow us on twitter : @imarcglobal

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Cervical Cancer Diagnostics Market to Grow at 4.56% During 2025-2033, Impelled by Awareness Campaigns
Purchase Options Discount
Offer
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials